age

Comparison of Basketball-Related Injuries at US Emergency Departments Between High School-Aged and College-Aged Athletes: A 10-Year NEISS Analysis, 2015-2024

Study Overview The research provides a comprehensive analysis of basketball-related injuries recorded in U.S. emergency departments over a decade, specifically

Comparison of Basketball-Related Injuries at US Emergency Departments Between High School-Aged and College-Aged Athletes: A 10-Year NEISS Analysis, 2015-2024 Read Post »

Comparison of Basketball-Related Injuries at US Emergency Departments Between High School-Aged and College-Aged Athletes: A 10-Year NEISS Analysis, 2015-2024

Injury Patterns in High School Athletes High school basketball athletes have unique injury profiles influenced by various factors, including developmental

Comparison of Basketball-Related Injuries at US Emergency Departments Between High School-Aged and College-Aged Athletes: A 10-Year NEISS Analysis, 2015-2024 Read Post »

Comparative risks of dementia and Parkinson’s disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study

Study Overview This study investigates the comparative risks associated with dementia and Parkinson’s disease in obese individuals suffering from type

Comparative risks of dementia and Parkinson’s disease with GLP-1 RAs versus other oral glucose-lowering medications in obese patients with type 2 diabetes: a large real-world cohort study Read Post »

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study

Study Overview The study was designed as a phase 2b clinical trial to evaluate the efficacy and safety of rezpegaldesleukin

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study Read Post »

Three-month versus twelve-month dual antiplatelet therapy after acute coronary syndrome: An updated meta-analysis of randomized trials with trial sequential analysis

Study Overview This research aimed to assess and compare the efficacy and safety of three-month versus twelve-month dual antiplatelet therapy

Three-month versus twelve-month dual antiplatelet therapy after acute coronary syndrome: An updated meta-analysis of randomized trials with trial sequential analysis Read Post »

Scroll to Top